$PBYI,,,Several nice upgrades. Big day yesterday w
Post# of 22756
Shares of Puma Biotechnology Inc. ( PBYI ) rose over 29% on Wednesday, following the FDA panel's support for approval of the Company's breast cancer drug Neratinib.
The FDA panel voted 12 - 4 to recommend approval of Neratinib for the extended adjuvant treatment of HER2-positive early stage breast cancer. The FDA usually follows the recommendations of its advisory panels, although it is not required to do so.
The U.S. regulatory agency's decision is expected to be announced in the third quarter of 2017.
PBYI
Read more: http://www.nasdaq.com/article/aeri-is-awesome...z4i5Lj5AZK
https://twitter.com/twitter/statuses/957208055766241280